161 related articles for article (PubMed ID: 34540365)
1. Measuring walking impairment in patients with intermittent claudication: psychometric properties of the Walking Estimated-Limitation Calculated by History (WELCH) questionnaire.
Rezvani F; Härter M; Dirmaier J
PeerJ; 2021; 9():e12039. PubMed ID: 34540365
[TBL] [Abstract][Full Text] [Related]
2. Validation of a Brazilian Portuguese Version of the Walking Estimated-Limitation Calculated by History (WELCH).
Cucato GG; Correia Mde A; Farah BQ; Saes GF; Lima AH; Ritti-Dias RM; Wolosker N
Arq Bras Cardiol; 2016 Jan; 106(1):49-55. PubMed ID: 26647720
[TBL] [Abstract][Full Text] [Related]
3. Treadmill Measured vs. Questionnaire Estimated Changes in Walking Ability in Patients With Peripheral Artery Disease.
Henni S; Ammi M; Semporé Y; Hersant J; Zegar G; Gourdier AS; Picquet J; Abraham P
Eur J Vasc Endovasc Surg; 2019 May; 57(5):676-684. PubMed ID: 30982731
[TBL] [Abstract][Full Text] [Related]
4. Validation of the English version of the Walking Estimated-Limitation Calculated by History (WELCH) questionnaire in patients with intermittent claudication.
Tew GA; Nawaz S; Humphreys L; Ouedraogo N; Abraham P
Vasc Med; 2014 Feb; 19(1):27-32. PubMed ID: 24452834
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of the Walking Estimated-Limitation Calculated by History questionnaire in patients with claudication.
Ouedraogo N; Chanut M; Aubourg M; Le Hello C; Hidden V; Audat G; Harbonnier M; Abraham P
J Vasc Surg; 2013 Oct; 58(4):981-8. PubMed ID: 23663870
[TBL] [Abstract][Full Text] [Related]
6. Measurement properties of walking outcome measures for neurogenic claudication: a systematic review and meta analysis.
Anderson DB; Mathieson S; Eyles J; Maher CG; Van Gelder JM; Tomkins-Lane CC; Ammendolia C; Bella V; Ferreira ML
Spine J; 2019 Aug; 19(8):1378-1396. PubMed ID: 30986579
[TBL] [Abstract][Full Text] [Related]
7. External validation of the "walking estimated limitation calculated by history" (WELCH) questionnaire in patients with claudication.
Abraham P; Godet R; Harbonnier M; Laneelle D; Leftheriotis G; Ouedraogo N
Eur J Vasc Endovasc Surg; 2014 Mar; 47(3):319-25. PubMed ID: 24445082
[TBL] [Abstract][Full Text] [Related]
8. Translation and Validation of the Brazilian-Portuguese Short Version of Vascular Quality of Life Questionnaire in Peripheral Artery Disease Patients with Intermittent Claudication Symptoms.
de Almeida Correia M; Andrade-Lima A; Mesquita de Oliveira PL; Domiciano RM; Ribeiro Domingues WJ; Wolosker N; Puench-Leão P; Ritti-Dias RM; Cucato GG
Ann Vasc Surg; 2018 Aug; 51():48-54.e1. PubMed ID: 29772330
[TBL] [Abstract][Full Text] [Related]
9. Use of the Walking Impairment Questionnaire and Walking Estimated-Limitation Calculated by History questionnaire to detect maximal walking distance equal to or lower than 250 m in patients with lower extremity arterial disease.
Tollenaere Q; Métairie A; Le Pabic E; Le Faucheur A; Mahé G
Front Cardiovasc Med; 2023; 10():968213. PubMed ID: 37025694
[TBL] [Abstract][Full Text] [Related]
10. Vascular Quality of Life Questionnaire-6 facilitates health-related quality of life assessment in peripheral arterial disease.
Nordanstig J; Wann-Hansson C; Karlsson J; Lundström M; Pettersson M; Morgan MB
J Vasc Surg; 2014 Mar; 59(3):700-7. PubMed ID: 24342060
[TBL] [Abstract][Full Text] [Related]
11. Claudication distances and the Walking Impairment Questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease.
Myers SA; Johanning JM; Stergiou N; Lynch TG; Longo GM; Pipinos II
J Vasc Surg; 2008 Mar; 47(3):550-555. PubMed ID: 18207355
[TBL] [Abstract][Full Text] [Related]
12. The correlation of the "Walking Estimated-Limitation Calculated by History" (WELCH) questionnaire with treadmill maximal walking time is not impaired by age, in patients with claudication.
Fouasson-Chailloux A; Abraham P; Vielle B; Laporte I; Omarjee L; Ouedraogo N
Qual Life Res; 2015 Aug; 24(8):1857-64. PubMed ID: 25578404
[TBL] [Abstract][Full Text] [Related]
13. Simple assessment of quality of life and lower limb functional capacity during cilostazol treatment - results of the SHort-tERm cIlostazol eFFicacy and quality of life (SHERIFF) study.
Farkas K; Kolossváry E; Járai Z
Vasa; 2020 Apr; 49(3):235-242. PubMed ID: 31983287
[No Abstract] [Full Text] [Related]
14. Effectiveness of a Medical vs Revascularization Intervention for Intermittent Leg Claudication Based on Patient-Reported Outcomes.
Devine EB; Alfonso-Cristancho R; Yanez ND; Edwards TC; Patrick DL; Armstrong CA; Devlin A; Symons RG; Meissner MH; Derrick EL; Lavallee DC; Kessler LG; Flum DR;
JAMA Surg; 2016 Oct; 151(10):e162024. PubMed ID: 27760274
[TBL] [Abstract][Full Text] [Related]
15. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Journal of the American Medical Association 2013; 309: 453-460.
Kurklinsky AK; Levy M
Vasc Med; 2013 Aug; 18(4):234-6. PubMed ID: 23867841
[TBL] [Abstract][Full Text] [Related]
16. [Cilostazol improves the quality of life and lower-limb functional capacity also in diabetic patients].
Farkas K; Kolossváry E; Járai Z
Orv Hetil; 2020 Sep; 161(38):1637-1645. PubMed ID: 32924968
[TBL] [Abstract][Full Text] [Related]
17. Validation of a new simple questionnaire to "estimate ambulation capacity by history" (EACH) in patients with claudication.
Ouedraogo N; Mahe G; Marchand J; Saïdi K; Leftheriotis G; Abraham P
J Vasc Surg; 2011 Jul; 54(1):133-8. PubMed ID: 21334169
[TBL] [Abstract][Full Text] [Related]
18. Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial.
McDermott MM; Liu K; Guralnik JM; Criqui MH; Spring B; Tian L; Domanchuk K; Ferrucci L; Lloyd-Jones D; Kibbe M; Tao H; Zhao L; Liao Y; Rejeski WJ
JAMA; 2013 Jul; 310(1):57-65. PubMed ID: 23821089
[TBL] [Abstract][Full Text] [Related]
19. Assessing the quality of available patient reported outcome measures for intermittent claudication: a systematic review using the COSMIN checklist.
Conijn AP; Jens S; Terwee CB; Breek JC; Koelemay MJ
Eur J Vasc Endovasc Surg; 2015 Mar; 49(3):316-34. PubMed ID: 25618453
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
